00000cam 2200000zi 4500 9.965445 CaOODSP 20260924111638 m o d f cr cn||||||||| 260826s2025 onca os f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- y1y2 H82-60/2025E-PDF Biosimilars in Canada : policies to promote switching and what it means for payers. [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025] 1 online resource (11 pages) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Les médicaments biosimilaires au Canada : politiques visant à favoriser la substitution et ce qu'elles signifient pour les payeurs. "Presentation to the 2025 Annual CAHSPR Conference, May 2025." "Presented by: Yvonne Zhang, Senior Economist." "NPDUIS Research Initiative, Patented Medicine Prices Review Board." Biosimilars Canada Statistics. Biologicals Canada Statistics. Pharmaceutical industry Canada Statistics. Statistics lcgft Zhang, Yvonne. Canada. Patented Medicine Prices Review Board, issuing body. Les médicaments biosimilaires au Canada : (CaOODSP)9.966216 PDF 231 KB https://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-60-2025-eng.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/slide-presentations/cahspr2025-biosimilars.html